First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...
Advancing Gold Exploration, Antimony Development, and US Redomiciliation Melbourne, Australia, April 29, 2026 (GLOBE NEWSWIRE ...
Advancing Gold Exploration, Antimony Development, and US Redomiciliation Melbourne, Australia, April 29, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Limited ("Nova" and the ...